The cellular and molecular alterations associated with synapse and neuron loss in Alzheimer’s disease (AD) remain unclear. In transgenic mouse models that express mutations responsible for familial AD, neuronal and synaptic losses occur in populations that accumulate fibrillar amyloid-β 42 (Aβ42) intracellularly.
Objective:
We aimed to study the subcellular localization of these fibrillar accumulations and whether such intraneuronal assemblies could be observed in the human pathology.
Methods:
We used immunolabeling and various electron microscopy techniques on APP x presenilin1 - knock-in mice and on human cortical biopsies and postmortem samples.
Results:
We found an accumulation of Aβ fibrils in lipofuscin granule-like organelles in APP x presenilin1 - knock-in mice. Electron microscopy of human cortical biopsies also showed an accumulation of undigested material in enlarged lipofuscin granules in neurons from AD compared to age-matched non-AD patients. However, in those biopsies or in postmortem samples we could not detect intraneuronal accumulations of Aβ fibrils, neither in the lipofuscin granules nor in other intraneuronal compartments.
Conclusion:
The intralysosomal accumulation of Aβ fibrils in specific neuronal populations in APPxPS1-KI mice likely results from a high concentration of Aβ42 in the endosome-lysosome system due to the high expression of the transgene in these neurons.
SelkoeDJ, HardyJ (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med8, 595–608.
2.
SzarugaM, VeugelenS, BenurwarM, LismontS, Sepulveda-FallaD, LleoA, RyanNS, LashleyT, FoxNC, MurayamaS, GijsenH, De StrooperB, Chávez-GutiérrezL (2015) Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease. J Exp Med212, 2003–2013.
3.
CataldoAM, PetanceskaS, TerioNB, PeterhoffCM, DurhamR, MerckenM, MehtaPD, BuxbaumJ, HaroutunianV, NixonRA (2004) Abeta localization in abnormal endosomes: Association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging25, 1263–1272.
4.
GourasGK, TsaiJ, NaslundJ, VincentB, EdgarM, CheclerF, GreenfieldJP, HaroutunianV, BuxbaumJD, XuH, GreengardP, RelkinNR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol156, 15–20.
5.
GourasGK, TampelliniD, TakahashiRH, Capetillo-ZarateE (2010) Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer’s disease. Acta Neuropathol119, 523–541.
6.
LanguiD, GirardotN, El HachimiKH, AllinquantB, BlanchardV, PradierL, DuyckaertsC (2004) Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am J Pathol165, 1465–1477.
7.
TakahashiRH, MilnerTA, LiF, NamEE, EdgarMA, YamaguchiH, BealMF, XuH, GreengardP, GourasGK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol161, 1869–1879.
8.
TakahashiRH, AlmeidaCG, KearneyPF, YuF, LinMT, MilnerTA, GourasGK (2004) Oligomerization of Alzheimer’s beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci24, 3592–3599.
9.
CasasC, SergeantN, ItierJ-M, BlanchardV, WirthsO, van der KolkN, VingtdeuxV, van de SteegE, RetG, CantonT, DrobecqH, ClarkA, BoniciB, DelacourteA, BenavidesJ, SchmitzC, TrempG, BayerTA, BenoitP, PradierL (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol165, 1289–1300.
10.
OakleyH, ColeSL, LoganS, MausE, ShaoP, CraftJ, Guillozet-BongaartsA, OhnoM, DisterhoftJ, Van EldikL, BerryR, VassarR (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J Neurosci26, 10129–10140.
11.
CataldoAM, NixonRA (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A87, 3861–3865.
12.
SumpterPQ, MannDM, DaviesCA, YatesPO, SnowdenJS, NearyD (1986) An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer’s disease. Neuropathol Appl Neurobiol12, 305–319.
13.
TerryRD, GonatasNK, WeissM (1964) Ultrastructural studies in Alzheimer’s presenile dementia. Am J Pathol44, 269–297.
14.
AndrouinA, PotierB, NägerlUV, CattaertD, DanglotL, ThierryM, YoussefI, TrillerA, DuyckaertsC, El HachimiKH, DutarP, DelatourB, MartyS (2018) Evidence for altered dendritic spine compartmentalization in Alzheimer’s disease and functional effects in a mouse model. Acta Neuropathol135, 839–854.
15.
el HachimiKH, VergaL, GiacconeG, TagliaviniF, FrangioneB, BugianiO, FoncinJF (1991) Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients. Neurosci Lett129, 119–122.
16.
el HachimiKH, FoncinJF (1994) Do microglial cells phagocyte the beta/A4-amyloid senile plaque core of Alzheimer disease?C R Acad Sci III317, 445–451.
17.
SherringtonR, RogaevEI, LiangY, RogaevaEA, LevesqueG, IkedaM, ChiH, LinC, LiG, HolmanK, TsudaT, MarL, FoncinJF, BruniAC, MontesiMP, SorbiS, RaineroI, PinessiL, NeeL, ChumakovI, PollenD, BrookesA, SanseauP, PolinskyRJ, WascoW, Da SilvaHA, HainesJL, Perkicak-VanceMA, TanziRE, RosesAD, FraserPE, RommensJM, St George-HyslopPH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature375, 754–760.
ThalDR, RübU, OrantesM, BraakH (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology58, 1791–1800.
20.
BreyhanH, WirthsO, DuanK, MarcelloA, RettigJ, BayerTA (2009) APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy. Acta Neuropathol117, 677–685.
21.
FaureA, VerretL, BozonB, El Tannir El TayaraN, LyM, KoberF, DhenainM, RamponC, DelatourB (2011) Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer’s disease. Neurobiol Aging32, 407–418.
22.
WirthsO, BreyhanH, SchäferS, RothC, BayerTA (2008) Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer’s disease. Neurobiol Aging29, 891–901.
23.
HatamiA, AlbayR, MonjazebS, MiltonS, GlabeC (2014) Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem289, 32131–32143.
24.
HorellouS, PascualO, TrillerA, MartyS (2014) Adaptive and non-adaptive changes in activity-deprived presynaptic terminals. Eur J Neurosci39, 61–71.
ChengX-T, XieY-X, ZhouB, HuangN, Farfel-BeckerT, ShengZ-H (2018) Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons. J Cell Biol217, 3127–3139.
27.
SekhonSS, MaxwellDS (1974) Ultrastructural changes in neurons of the spinal anterior horn of ageing mice with particular reference to the accumulation of lipofuscin pigment. J Neurocytol3, 59–72.
28.
LauritzenI, Pardossi-PiquardR, BauerC, BrighamE, AbrahamJ-D, RanaldiS, FraserP, St-George-HyslopP, Le ThucO, EspinV, ChamiL, DunysJ, CheclerF (2012) The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J Neurosci32, 16243–16255.
29.
SannerudR, EsselensC, EjsmontP, MatteraR, RochinL, TharkeshwarAK, De BaetsG, De WeverV, HabetsR, BaertV, VermeireW, MichielsC, GrootAJ, WoutersR, DillenK, VintsK, BaatsenP, MunckS, DeruaR, WaelkensE, BasiGS, MerckenM, VooijsM, BollenM, SchymkowitzJ, RousseauF, BonifacinoJS, Van NielG, De StrooperB, AnnaertW (2016) Restricted location of PSEN2/γ-secretase determines substrate specificity and generates an intracellular Aβ pool. Cell166, 193–208.
30.
EsbjörnerEK, ChanF, ReesE, ErdelyiM, LuheshiLM, BertonciniCW, KaminskiCF, DobsonCM, Kaminski SchierleGS (2014) Direct observations of amyloid β self-assembly in live cells provide insights into differences in the kinetics of Aβ(1-40) and Aβ(1-42) aggregation. Chem Biol21, 732–742.
31.
HuX, CrickSL, BuG, FriedenC, PappuR V, LeeJ-M (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A106, 20324–20329.
32.
MannDM, YatesPO, StampJE (1978) The relationship between lipofuscin pigment and ageing in the human nervous system. J Neurol Sci37, 83–93.
33.
MrakRE, GriffinST, GrahamDI (1997) Aging-associated changes in human brain. J Neuropathol Exp Neurol56, 1269–1275.
34.
OenzilF, KishikawaM, MizunoT, NakanoM (1994) Age-related accumulation of lipofuscin in three different regions of rat brain. Mech Ageing Dev76, 157–163.
35.
YinD, ChenK (2005) The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol40, 455–465.
36.
DowsonJH, MountjoyCQ, CairnsMR, Wilton-CoxH (1995) Alzheimer’s disease: Distribution of changes in intraneuronal lipopigment in the frontal cortex. Dementia6, 334–342.
37.
MannDM, SinclairKG (1978) The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia. Neuropathol Appl Neurobiol4, 129–135.
38.
MannDM, YatesPO, MarcyniukB (1984) Relationship between pigment accumulation and age in Alzheimer’s disease and Down syndrome. Acta Neuropathol63, 72–77.
39.
BrunkUT, TermanA (2002) Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med33, 611–619.
40.
Moreno-GarcíaA, KunA, CaleroO, MedinaM, CaleroM (2018) An overview of the role of lipofuscin in age-related neurodegeneration. Front Neurosci12, 464.
41.
RossJA, MathewsPM, Van BockstaeleEJ (2019) High resolution approaches for the identification of amyloid fragments in brain. J Neurosci Methods319, 7–15.
42.
CataldoAM, PeterhoffCM, TroncosoJC, Gomez-IslaT, HymanBT, NixonRA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations. Am J Pathol157, 277–286.
43.
HungCOY, LiveseyFJ (2018) Altered γ-secretase processing of APP disrupts lysosome and autophagosome function in monogenic Alzheimer’s disease. Cell Rep25, 3647–3660.e2.
44.
SmallSA, KentK, PierceA, LeungC, KangMS, OkadaH, HonigL, VonsattelJ-P, KimT-W (2005) Model-guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol58, 909–919.
45.
SmallSA, Simoes-SpassovS, MayeuxR, PetskoGA (2017) Endosomal traffic jams represent a pathogenic hub and therapeutic target in Alzheimer’s disease. Trends Neurosci40, 592–602.
